Interface Engineering of Carrier-Protein-Dependent Metabolic Pathways
ACS Chemical Biology · 2023
DOI: 10.1021/acschembio.3c00238 ↗At a glance
Journal article in ACS Chemical Biology, 2023. Written by Terra Sztain and 9 co-authors. Institution: Department of Chemistry and Biochemistry, University of California San Diego, 9500 Gilman Drive, La Jolla, California 92093, United States. Major MEDLINE topics: Carrier Proteins, Acyl Carrier Protein. Cited 2 times so far (Crossref); 37 references. The full text is freely available in PubMed Central. Funded by: NIGMS NIH HHS, NIAID NIH HHS, NHLBI NIH HHS.
Abstract (original language)
Carrier-protein-dependent metabolic pathways biosynthesize fatty acids, polyketides, and non-ribosomal peptides, producing metabolites with important pharmaceutical, environmental, and industrial properties. Recent findings demonstrate that these pathways rely on selective communication mechanisms involving protein-protein interactions (PPIs) that guide enzyme reactivity and timing. While rational design of these PPIs could enable pathway design and modification, this goal remains a challenge due to the complex nature of protein interfaces. Computational methods offer an encouraging avenue, though many score functions fail to predict experimental observables, leading to low success rates. Here, we improve upon the Rosetta score function, leveraging experimental data through iterative rounds of computational prediction and mutagenesis, to design a hybrid fatty acid-non-ribosomal peptide initiation pathway. By increasing the weight of the electrostatic score term, the computational protocol proved to be more predictive, requiring fewer rounds of iteration to identify mutants with high in vitro activity. This allowed efficient design of new PPIs between a non-ribosomal peptide synthetase adenylation domain, PltF, and a fatty acid synthase acyl carrier protein, AcpP, as validated by activity and structural studies. This method provides a promising platform for customized pathway design, establishing a standard for carrier-protein-dependent pathway engineering through PPI optimization.
Subjects
MeSH terms (MEDLINE)
Substances
Authors and institutions
- Department of Chemistry and Biochemistry, University of California San Diego, 9500 Gilman Drive, La Jolla, California 92093, United States.
ORCID profiles: Terra Sztain, J Andrew McCammon, Michael D Burkart
Funding
- NIGMS NIH HHS
- NIAID NIH HHS
- NHLBI NIH HHS
- National Heart, Lung, and Blood Institute
- Division of Graduate Education
- National Institute of General Medical Sciences
Cite
APA
Sztain, T., Corpuz, J. C., Bartholow, T. G., Sanlley Hernandez, J. O., Jiang, Z., Mellor, D. A., Heberlig, G. W., La Clair, J. J., McCammon, J. A., & Burkart, M. D. (2023). Interface Engineering of Carrier-Protein-Dependent Metabolic Pathways. ACS Chemical Biology. https://doi.org/10.1021/acschembio.3c00238
Vancouver
Sztain T, Corpuz JC, Bartholow TG, Sanlley Hernandez JO, Jiang Z, Mellor DA, et al. Interface Engineering of Carrier-Protein-Dependent Metabolic Pathways. ACS Chemical Biology. 2023. doi:10.1021/acschembio.3c00238
BibTeX
@article{Sztain2023,
author = {Sztain, Terra and Corpuz, Joshua C and Bartholow, Thomas G and Sanlley Hernandez, Javier O and Jiang, Ziran and Mellor, Desirae A and Heberlig, Graham W and La Clair, James J and McCammon, J Andrew and Burkart, Michael D},
title = {Interface Engineering of Carrier-Protein-Dependent Metabolic Pathways},
journal = {ACS Chemical Biology},
year = {2023},
doi = {10.1021/acschembio.3c00238}
}
EUVIMED